BEAM
Beam Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$27.23
−5.58%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 53.23x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.63x
- Price / sales
- 18.02x
- Price / cash flow
- -7.83x
Enterprise value
- Enterprise value
- $1.9B
- EV / sales
- 12.22x
- EV / EBITDA
- -30.18x
- EV / EBIT
- -5.04x
- Market cap
- $2.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026